The rising prevalence in GLP-1 agonists for metabolic conditions has led to a debate about formats: patches versus capsules. Traditionally , GLP-1 treatments were only available in oral form, but the https://zoyasrko709565.vidublog.com/39685253/glp-1-transdermal-delivery-systems-vs-pills-which-best-for-individuals